Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of pyroptosis in hepatocellular carcinoma
Zhimiao Zou, Minghui Zhao, Yang Yang, et al.
Cellular Oncology (2023) Vol. 46, Iss. 4, pp. 811-823
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation
Zhouxiang Liao, Lichao Yang, Xiaojing Cheng, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification
Guoqing Ouyang, Qiuyun Li, Yangnian Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Pyroptosis Induction with Nanosonosensitizer‐Augmented Sonodynamic Therapy Combined with PD‐L1 Blockade Boosts Efficacy against Liver Cancer
Nisi Zhang, Wenlong Zeng, Yunxue Xu, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 7
Closed Access | Times Cited: 18
Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis
Wei Xie, Leiying Zhang, Junjing Shen, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
Jinfeng Zhu, Qian Huang, Xingyu Peng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Burning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma
Chi Cheng, Sheng‐Kai Hsu, Yen‐Chun Chen, et al.
Life Sciences (2024) Vol. 347, pp. 122627-122627
Closed Access | Times Cited: 4
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma
Anna Tutusaus, Marco Sanduzzi‐Zamparelli, Loreto Boix, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1491-1491
Open Access | Times Cited: 4
Programmed cell death protein 5 inhibits hepatocellular carcinoma progression by inducing pyroptosis through regulation of TGF-β/Smad2/3/Snail pathway
Yiqiao Wang, Shihao Huang, Ying Cai, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167696-167696
Closed Access
Study on the Mechanism of QRICH1 Mediating PRMT1 to Regulate the Arginine Methylation Modification of cGAS to Promote Arsenics-Induced Pyroptosis in Hepatocellular Carcinoma Cells
Jiayuan Zhang, Tian Tian, Shanshan Tian, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 597-614
Open Access
Can pyridoxine function as an anti-pyroptosis agent? A narrative review
Astari Pranindya Sari, Reviono Reviono, Agus Dwi Susanto, et al.
Inflammopharmacology (2025)
Closed Access
Knockdown of PAK1IP1 can Induce Pyroptosis to Inhibit the Progression of Hepatocellular Carcinoma
Xiaoliang Lü, Jie Chen, Zefa Lu, et al.
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access
Icaritin Exerts Anti-Cancer Effects through Modulating Pyroptosis and Immune Activities in Hepatocellular Carcinoma
Yuanyuan Jiao, Wenqian Li, Wen Yang, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1917-1917
Open Access | Times Cited: 3
Multinomial classification of NLRP3 inhibitory compounds based on large scale machine learning approaches
Muhammad Ishfaq, Syed Zahid Ali Shah, Ijaz Ahmad, et al.
Molecular Diversity (2023) Vol. 28, Iss. 4, pp. 1849-1868
Closed Access | Times Cited: 8
Pyroptosis: Induction and inhibition strategies for immunotherapy of diseases
Junjun Wu, Hong Wang, Pu Gao, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 10, pp. 4195-4227
Open Access | Times Cited: 2
Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma
Haoran Wang, Xian Shui, Zheng Zhang, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 6, pp. 2799-2811
Open Access | Times Cited: 1
The phosphorylation of Smad3 by CaMKIIγ leads to the hepatocyte pyroptosis under perfluorooctane sulfonate exposure
Siyu Ren, Peiyao Liang, Ruzhen Feng, et al.
Ecotoxicology and Environmental Safety (2024) Vol. 284, pp. 116924-116924
Open Access | Times Cited: 1
Cinobufotalin inhibits proliferation, migration and invasion in hepatocellular carcinoma by triggering NOX4/NLRP3/GSDMD-dependent pyroptosis
Chen Liu, Jianmin Wu, Zhiwen Li, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
TENT5A mediates the cancer-inhibiting effects of EGR1 by suppressing the protein stability of RPL35 in hepatocellular carcinoma
Xuejie Min, Fen Lin, Xinge Zhao, et al.
Cellular Oncology (2024)
Closed Access | Times Cited: 1
Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases
Wanvisa Udomsinprasert
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 11, pp. 1125-1143
Closed Access | Times Cited: 2
The Risk Signature of Pyroptosis-Related Long Noncoding RNAs Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular carcinoma
Wenjie Zhang, Xu Chen, Qiang Meng, et al.
Research Square (Research Square) (2024)
Open Access
Development and validation of a pyroptosis-related prognostic signature associated with osteosarcoma metastasis and immune infiltration
Zhenyu Gong, Yimo Wan, Enen Han, et al.
Medicine (2024) Vol. 103, Iss. 14, pp. e37642-e37642
Open Access
The new epigenetic driver role of PPARα and mitochondria in metabolic dysfunction associated liver disease (MASLD), paving the way towards new therapeutics and diagnostic biomarkers
Claudia Theys
(2024)
Open Access
Recent Advances in RNA Interference-Based Therapy for Hepatocellular Carcinoma: Emphasis on siRNA
Mohammad S. Alzahrani, Bandar Almutairy, Yusuf S. Althobaiti, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1947-1964
Closed Access
Pyroptosis and chemical classification of pyroptotic agents
Mohammed A Hara, Mohamed Ramadan, Mohammed K. Abdelhameid, et al.
Molecular Diversity (2024)
Open Access
Gu Sui Bu (Drynaria fortunei J. Smith) prevents osteoporosis in ovariectomized rats by inhibiting pyroptosis through NLRP3/GSDMD/CASPASE-1
Hui Su, Jun Dong, Luyao Liu, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 13, pp. 100544-100544
Open Access
Page 1 - Next Page

Scroll to top